Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CONTINUOUS INTRAVENOUS EPOPROSTENOL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 17 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Russo-Magno, PM; Hill, NS
      New approaches to pulmonary hypertension

      HOSPITAL PRACTICE
    2. Stricker, H; Domenighetti, G; Popov, W; Speich, R; Nicod, L; Aubert, JD; Soler, M
      Severe pulmonary hypertension: data from the Swiss Registry

      SWISS MEDICAL WEEKLY
    3. Wilkins, MR; Wharton, J
      Progress in, and future prospects for, the treatment of primary pulmonary hypertension

      HEART
    4. Vizza, CD; Sciomer, S; Morelli, S; Lavalle, C; Di Marzio, P; Padovani, D; Badagliacca, R; Vestri, AR; Naeije, R; Fedele, F
      Long term treatment of pulmonary arterial hypertension with beraprost, an oral prostacyclin analogue

      HEART
    5. Bailey, CL; Channick, RN; Rubin, LJ
      A new era in the treatment of primary pulmonary hypertension

      HEART
    6. Schermuly, RT; Krupnik, E; Tenor, H; Schudt, C; Weissmann, N; Rose, F; Grimminger, F; Seeger, W; Walmrath, D; Ghofrani, HA
      Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension - Maintenance of lung selectivity

      AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
    7. Galie, N
      Do we need controlled clinical trials in pulmonary arterial hypertension?

      EUROPEAN RESPIRATORY JOURNAL
    8. McLaughlin, VV; Rich, S
      Severe pulmonary hypertension: Critical care clinics

      CRITICAL CARE CLINICS
    9. Denton, CP; Black, CM
      Combination therapies for systemic sclerosis

      SPRINGER SEMINARS IN IMMUNOPATHOLOGY
    10. Tuder, RM; Cool, CD; Yeager, M; Taraseviciene-Stewart, L; Bull, TM; Voelkel, NE
      The pathobiology of pulmonary hypertension - Endothelium

      CLINICS IN CHEST MEDICINE
    11. Barst, RJ
      Medical therapy of pulmonary hypertension - An overview of treatment and goals

      CLINICS IN CHEST MEDICINE
    12. Galie, N; Manes, A; Branzi, A
      Medical therapy of pulmonary hypertension - The prostacyclins

      CLINICS IN CHEST MEDICINE
    13. Channick, RN; Simonneau, G; Sitbon, O; Robbins, IM; Frost, A; Tapson, VF; Badesch, DB; Roux, S; Rainisio, M; Bodin, F; Rubin, LJ
      Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study

      LANCET
    14. Klings, ES; Farber, HW
      Current management of primary pulmonary hypertension

      DRUGS
    15. Greidinger, EL; Gaine, SP; Wise, RA; Boling, C; Housten-Harris, T; Wigley, FM
      Primary pulmonary hypertension is not associated with scleroderma-like changes in nailfold capillaries

      CHEST
    16. Sebbag, I; Rudski, LG; Therrien, J; Hirsch, A; Langleben, D
      Effect of chronic infusion of Epoprostenol on echocardiographic right ventricular myocardial performance index and its relation to clinical outcome in patients with primary pulmonary hypertension

      AMERICAN JOURNAL OF CARDIOLOGY
    17. Matthes, J; Mathen, F; Herzig, S; Wassermann, K
      Treatment of severe pulmonary hypertension with prostacyclin and its analogue iloprost

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/06/20 alle ore 08:15:41